Biomarin
BioMarin develops and commercialises innovative biopharmaceuticals for rare diseases driven by genetic causes.
Financial Data
-
31st Dec 16 Source: CRO
- €377.3 million turnover
-
€0.1 million
profit - 236 employees
-
31st Dec 15 Source: CRO
- €241.5 million turnover
-
€0.2 million
profit - 158 employees
- 1 more year available »
Ranking
By Turnover
(€377.3 million)- 189th in Top Companies
- 26th in Health
By Employees
(236)- 534th in Top Companies
- 71st in Health
- 236
- €377.3 million
Employees
- Michael O’Donnell CEO/Managing Director
Latest News
- 12:01am Dublin Port will be shipshape and ready for a hard Brexit, says CEO
- Jan 17 Salesforce plans to add up to 1,500 jobs in Ireland
- Jan 17 Charity radio station Christmas FM raises €400,000 for hospital
- Jan 17 Germany considers barring China’s Huawei from 5G networks
- Jan 17 Ireland would be ‘screwed’ if UK crashes out of EU, exports chief warns